Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01413672 · ClinicalTrials.gov registry record
Preliminary Evaluation of CASTLE Barrier North American Prototype
A clinical trial, sponsored by Hollister Incorporated.
- Completed
- Registry status
- 30
- Enrollment target
NCT01413672: Completed study, sponsored by Hollister Incorporated.
NCT01413672 is a clinical trial that has completed, run by Hollister Incorporated. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01413672 has completed, sponsored by Hollister Incorporated.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if an ostomy barrier that promotes a healthy skin environment will result in reduced peristomal skin irritation.
Interventions
- DEVICE Use of CASTLE barrier
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2011-08 |
| Est. Completion | 2011-12 |
What the finished NCT01413672 record still lists
NCT01413672 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Use of CASTLE barrier is the first listed.
NCT01413672 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01413672 about?
NCT01413672 is a clinical study titled "Preliminary Evaluation of CASTLE Barrier North American Prototype". The purpose of this study is to determine if an ostomy barrier that promotes a healthy skin environment will result in reduced peristomal skin irritation.
What is the current status of trial NCT01413672?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2011-08. Estimated completion is 2011-12.
What interventions are being tested in trial NCT01413672?
The interventions under investigation include: Use of CASTLE barrier (DEVICE).
Who is sponsoring clinical trial NCT01413672?
This trial is sponsored by Hollister Incorporated, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia